The de novo missense mutation N117S in skeletal muscle α‑actin 1 causes a mild form of congenital nemaline myopathy

Yang,Liu; Yu,Ping; Chen,Xiang; Cai,Tao

doi:10.3892/mmr.2016.5429

The de novo missense mutation N117S in skeletal muscle α‑actin 1 causes a mild form of congenital nemaline myopathy

Authors:
- Liu Yang
- Ping Yu
- Xiang Chen
- Tao Cai
View Affiliations

Affiliations: Physical Medicine and Rehabilitation Center, The Second Afﬁliated Hospital and Yuying Children's Hospital, Wenzhou Medical University, Wenzhou, Zhejiang 325027, P.R. China, Institute of Genomic Medicine, Wenzhou Medical University, Wenzhou, Zhejiang 325027, P.R. China
Published online on: June 23, 2016 https://doi.org/10.3892/mmr.2016.5429
Pages: 1693-1696

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Nemaline myopathy (NM) constitutes a spectrum of primary skeletal muscle disorders, the diagnosis of which is based on muscle weakness and the visualization of nemaline bodies in muscle biopsies. Mutations in several NM causal genes have been attributed to the majority of NM cases, particularly mutations in nebulin and skeletal muscle α‑actin 1 (ACTA1), which are responsible for ~70% of cases; therefore, a genetic diagnostic strategy using targeted gene sequencing may potentially improve the diagnosis of suspected NM. The present study identified a de novo mutation in ACTA1 (c.350A>G; p.Asn117Ser) in a Chinese patient using target‑capture sequencing of a panel containing 125 known causal genes for inherited muscle diseases. Clinical analyses revealed that the case described in the present study exhibited a relatively mild phenotype with regards to muscle weakness, as compared with more severe phenotypes reported in several other patients with the same mutation, thus suggesting the existence of genetic modifiers. In conclusion, this approach may be helpful for the identification of clinically undiagnosed patients with highly heterogeneous disorders.

View Figures

View References

1	Wallgren-Pettersson C, Kääriäinen H, Rapola J, Salmi T, Jääskeläinen J and Donner M: Genetics of congenital nemaline myopathy: A study of 10 families. J Med Genet. 27:480–487. 1990. View Article : Google Scholar : PubMed/NCBI
2	Yin X, Pu CQ, Wang Q, Liu JX and Mao YL: Clinical and pathological features of patients with nemaline myopathy. Mol Med Rep. 10:175–182. 2014.PubMed/NCBI
3	Han Y, Zheng H and Ding S: Delayed onset of nemaline myopathy: A case report. Chin Med J (Engl). 116:798–800. 2003.
4	Jiang H, Xiao B, Jia DD, Zhang N, Xu XP and Tang BS: Clinical and pathologic analysis of an autosomal recessive kindred with nemaline myopathy. Zhonghua Yi Xue Za Zhi. 89:3316–3319. 2009.In Chinese.
5	Jiang C, Wang J and Lu H: Clinical and pathological features of childhood-onset nemaline myopathy: A report of four cases. Case Rep Med. 2012:2036022012.PubMed/NCBI
6	Chen Z, Wang JL, Tang BS, Sun ZF, Shi YT, Shen L, Lei LF, Wei XM, Xiao JJ, Hu ZM, et al: Using next-generation sequencing as a genetic diagnostic tool in rare autosomal recessive neurologic Mendelian disorders. Neurobiol Aging. 34:2442.e11–e17. 2013. View Article : Google Scholar
7	Romero NB, Sandaradura SA and Clarke NF: Recent advances in nemaline myopathy. Curr Opin Neurol. 26:519–526. 2013. View Article : Google Scholar : PubMed/NCBI
8	Garg A, O'Rourke J, Long C, Doering J, Ravenscroft G, Bezprozvannaya S, Nelson BR, Beetz N, Li L, Chen S, et al: KLHL40 deficiency destabilizes thin filament proteins and promotes nemaline myopathy. J Clin Invest. 124:3529–3539. 2014. View Article : Google Scholar : PubMed/NCBI
9	Sztal TE, Zhao M, Williams C, Oorschot V, Parslow AC, Giousoh A, Yuen M, Hall TE, Costin A, Ramm G, et al: Zebrafish models for nemaline myopathy reveal a spectrum of nemaline bodies contributing to reduced muscle function. Acta Neuropathol. 130:389–406. 2015. View Article : Google Scholar : PubMed/NCBI
10	Wallgren-Pettersson C, Sewry CA, Nowak KJ and Laing NG: Nemaline myopathies. Semin Pediatr Neurol. 18:230–238. 2011. View Article : Google Scholar : PubMed/NCBI
11	Tian L, Ding S, You Y, Li TR, Liu Y, Wu X, Sun L and Xu T: Leiomodin-3-deficient mice display nemaline myopathy with fast-myofiber atrophy. Dis Model Mech. 8:635–641. 2015. View Article : Google Scholar : PubMed/NCBI
12	Nowak KJ, Wattanasirichaigoon D, Goebel HH, Wilce M, Pelin K, Donner K, Jacob RL, Hübner C, Oexle K, Anderson JR, et al: Mutations in the skeletal muscle alpha-actin gene in patients with actin myopathy and nemaline myopathy. Nat Genet. 23:208–212. 1999. View Article : Google Scholar : PubMed/NCBI
13	Ilkovski B, Cooper ST, Nowak K, Ryan MM, Yang N, Schnell C, Durling HJ, Roddick LG, Wilkinson I, Kornberg AJ, et al: Nemaline myopathy caused by mutations in the muscle alpha-skeletal-actin gene. Am J Hum Genet. 68:1333–1343. 2001. View Article : Google Scholar : PubMed/NCBI
14	Sparrow JC, Nowak KJ, Durling HJ, Beggs AH, Wallgren-Pettersson C, Romero N, Nonaka I and Laing NG: Muscle disease caused by mutations in the skeletal muscle alpha-actin gene (ACTA1). Neuromuscul Disord. 13:519–531. 2003. View Article : Google Scholar : PubMed/NCBI
15	Shy GM, Engel WK, Somers JE and Wanko T: Nemaline Myopathy. A new congenital myopathy. Brain. 86:793–810. 1963. View Article : Google Scholar : PubMed/NCBI
16	North KN and Ryan MM: Nemaline myopathy. GeneReviews^® [Internet]. Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Fong CT, Mefford HC, Smith RJH and Stephens K: University of Washington; Seattle, WA: 1993–2016
17	Bathe FS, Rommelaere H and Machesky LM: Phenotypes of myopathy-related actin mutants in differentiated C2C12 myotubes. BMC Cell Biol. 8:22007. View Article : Google Scholar : PubMed/NCBI
18	Costa CF, Rommelaere H, Waterschoot D, Sethi KK, Nowak KJ, Laing NG, Ampe C and Machesky LM: Myopathy mutations in alpha-skeletal-muscle actin cause a range of molecular defects. J Cell Sci. 117:3367–3377. 2004. View Article : Google Scholar : PubMed/NCBI
19	Sambuughin N, Zvaritch E, Kraeva N, Sizova O, Sivak E, Dickson K, Weglinski M, Capacchione J, Muldoon S, Riazi S, et al: Exome analysis identifies Brody myopathy in a family diagnosed with malignant hyperthermia susceptibility. Mol Genet Genomic Med. 2:472–483. 2014. View Article : Google Scholar
20	Langouet M, Siquier-Pernet K, Sanquer S, Bole-Feysot C, Nitschke P, Boddaert N, Munnich A, Mancini GM, Barouki R, Amiel J and Colleaux L: Contiguous mutation syndrome in the era of high-throughput sequencing. Mol Genet Genomic Med. 3:215–220. 2015. View Article : Google Scholar : PubMed/NCBI
21	Yu P, Cui Y, Cai W, Wu H, Xiao X, Shao Q, Ma L, Guo S, Wu N, Jin ZB, et al: Lysosomal storage disease in the brain: Mutations of the β-mannosidase gene identified in autosomal dominant nystagmus. Genet Med. 17:971–979. 2015. View Article : Google Scholar : PubMed/NCBI
22	Cai T, Yang L, Cai W, Guo S, Yu P, Li J, Hu X, Yan M, Shao Q, Jin Y, et al: Dysplastic spondylolysis is caused by mutations in the diastrophic dysplasia sulfate transporter gene. Proc Natl Acad Sci USA. 112:8064–8069. 2015. View Article : Google Scholar : PubMed/NCBI